Immune Acute Complex: An herbal blend designed to provide an immediate boost to the immune system
Immune Acute Complex
Immune System support for when you actually have an infection. The formula designed for treatment, rather than prevention.
*note: A claim is not being made that this product will treat, cure or mitigate disease.*Who can benefit from this herbal formula? Those who need active, immediate immune system support. Examples would include the first sign of the flu, the common cold, etc.
Phyto-Tech™ Immune Acute Complex is a blend of herbs that are thought to exert a direct, stimulating effect on immune function.
Each serving (30 drops) contains the following: Astragalus Root 50 mg, Maitake Mushroom 50 mg, Shiitake Mushroom 50 mg, Fresh Echinacea angusifolia Root 75 mg, Forsythia Fruit 45 mg, Honeysuckle Flower 46 mg, Isatis Root 45 mg, Licorice Root 13 mg, Colloidal Silver 15 ppm, 0.05 ml, Garlic Bulb 13 mg, Beta-Glucan 5 mg, Eucalyptus Oil 0.6 mg, Menthol Crystals 1.5 mg, Deionized Water, Grain Alcohol.
Reference: “In Beijing, the Ditan Hospital reported that it used herbs to treat H1N1 patients and experienced a 75% success rate, with 88 of the 117 patients recovered.4 Patients were given a tea and mouthwash containing 3 grams each of 4 herbs, including Japanese honeysuckle flower, isatis (Isatis indigotica) (both leaf and root are used in TCM; the plant part for this formula was not specified), mint (Mentha spp.) leaves, and licorice (Glycyrrhiza uralensis) root. All of these herbs have documented uses in treating flu-related symptoms, such as fever, upper respiratory tract infections, headache, and sore throat.”1
Both Maitake and Shiitake mushroom have been prized for centuries in Asia for the medicinal value. “A vast amount of research has been conducted on their medicinal properties.”2
“Maitake (also known as Hen of the Woods) grows wild in the eastern U.S. as well as in Europe and Asia. The mushroom looks like a cross between a bundle of ribbons and a cauliflower. This author highly recommends it as a delicious, meatlike dish. Maitake apparently lowers blood pressure without changing plasma high density lipoprotein (HDL, or 'good' cholesterol) levels, whereas shiitake lowers HDL levels. Maitake appears to slow the metabolism of glucose in the blood, based on studies in mice. Human clinical trials on the effects of maitake on breast and colorectal cancers have been conducted in the U.S.; Chinese research indicates possible effectiveness in treating lung, stomach, and hepatocellular cancers as well as leukemia, and there is preliminary but promising research into maitake as a treatment for AIDS, particularly Kaposi's Sarcoma.”2
Maitake may elicit the most powerful immune system response of any of the medicinal mushrooms that are widely available.3
Mushrooms like maitake and shiitake have been shown to exert specific antiviral activity. “A new class of anti-viral compounds has been recently discovered in mushrooms. Frank Piraino, Ph.D., and Curtis Brandt, Ph.D., at the University of Wisconsin-Madison Medical School, found a new antiviral, RC-183, that shows in vitro activity in inhibiting the herpes simplex I and II viruses, as well as varicella zoster virus, influenza A virus, and the respiratory syncytial virus. The mushroom yielding this novel antiviral is Rozites caperata, the gypsy mushroom, a mycorrhizal species associated with pines (Pinus spp., Pinaceae) and Douglas-fir (Pseudotsuga menziesii (Mirb.) Franco, Pinaceae) with a wide range that includes the old growth coniferous forest in the Pacific Northwest, the East and Northern North America. This mushroom thrives in both coniferous and in hardwood forests and where huckleberry (Vaccinium ovalifolium Smith, Ericaceae) grows in the midwest.
“In a more recent article, Brandt and Piraino identified a new class of anti-viral compounds from mushrooms. Antivirals from other mushrooms have been identified previously from shiitake (lentinan and KS-2 from Lentinula edodes (Berk.) Singer, Polyporaceae), turkey tail (PSP and PSK from Trametes versicolor (L.:Fr.) Pil‡t, Polyporaceae), reishi (ganaderiol-F, ganoderic acid-§, lucidumol from Ganoderma lucidum (Fr.) Lloyd, Ganodermataceae), maitaki (3 branched §-1-6 glucans from Grifola frondosa (Dicks.:Fr.) S.F. Gray, Polyporaceae), and oyster mushroom (ubiquitin-like protein with anti-HIV activity from Pleurotus ostreatus (Jaqu.:Fr.) Kumm, Polyporaceae). . .
“The predominant mushrooms showing promise for their anti-viral activities are polypores -- the so-called woody conks that are now believed, through ongoing DNA research, to be the ancestors of most, if not all, gilled mushrooms. Interestingly, no poisonous polypores are known, whereas there are more than 100 species of poisonous gilled mushrooms, of which only perhaps 20 are deadly. Most of these anti-viral compounds from mushrooms are water soluble, and relatively heat-stable. Furthermore, most of the mushrooms mentioned and/or their mycelia can be cultured to commercially significant levels. The anti-viral compounds are present both in the mycelium and in the fruiting bodies.
“The current literature points to fungi, particularly those in the family Polyporaceae, as a rich frontier of new medicines. Many of these species are long-term residents of old growth forests, playing an essential role in nutrient recycling by decomposing aged trees. In a time when new anti-viral medicines are critically needed, mushrooms stand out as an untapped resource and deserve intensive studies.”4
“Astragalus stimulates the immune system in a number of ways. In vitro studies have shown astragalus saponins enhanced cytotoxicity of natural killer cells and lymphokine-activated killer cell activity, and restored steroid-inhibited natural killer cell activity. Astragalus appeared to have a protective effect on mice infected with a Japanese encephalitis virus. Another in vitro study showed that astragalus potentiated the immune-mediated antitumor activity of interleukin-2. An open, randomized trial demonstrated a dose-related increase in white blood cells after treating leukopenic patients with astragalus. Another study found that chemotherapy patients treated with an Asian ginseng-astragalus injection experienced reduced toxic effects from the chemotherapy, increased weight, and increased cellular immune function when compared with patients receiving chemotherapy alone.”5
Dosage: 30-60 drops, 1-2 times per day or as needed in juice or water. Increase frequency when in need.
1. International Report on Herbs and Swine Flu. HerbalEGram: Volume 6, Number 10, October 2009
2. Ger, E., J. Angelucci, and P. Coleman. Mushrooms: Enjoying Your Medicine. Delaware Medical Journal, March 1997, Vol. 69, No. 3, pp. 149-151.
3. Schar, Douglas. Grifola frondosa: A 'New' Immunostimulant? British Journal of Phytotherapy.
4. Stamets, P. New Anti-viral Compounds from Mushrooms. HerbalGram. 2000; 51:24 American Botanical Council
5. Bone, K and Morgan, M. Astragalus membranaceus - Astragalus MediHerb. Astragalus - Chinese Herb for Immune Enhancement and other Potential Benefits. HerbClip September 30, 1999.